Skip to main content
Skip to footer
Evelo
A phase I/II clinical trial of EDP1503 with pembrolizumab for triple-negative breast cancer
Home
/
Posters
/
A phase I/II clinical trial of EDP1503 with pembrolizumab for triple-negative breast cancer
December 11, 2020
by